Search research articles
Contact Us
Filters
Showing results (191-200 of 277) with videos related to
Page
of 28
Sort By:
JAMA Oncology
|
June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
JCO Precision Oncology
|
September 11, 2020
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers
Scooter Willis, Yuliang Sun, Mark Abramovitz, et al.
NPJ Breast Cancer
|
January 12, 2022
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
Sherene Loi, Roberto Salgado, Sylvia Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2019
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi, Damien Drubay, Sylvia Adams, et al.
Histopathology
|
March 3, 2024
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
Amy Ly, Victor Garcia, Kim R M Blenman, et al.
Journal of Pathology Informatics
|
December 9, 2021
A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study
Sarah N Dudgeon, Si Wen, Matthew G Hanna, et al.
JCO Precision Oncology
|
April 26, 2023
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis
Sherene Loi, Roberto Salgado, Peter Schmid, et al.
NPJ Digital Medicine
|
March 5, 2026
Clarifying validation terminologies in healthcare
Amanda Dy, Sandra M Buetow, Andrew J Bredemeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer
Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
Nature Medicine
|
June 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trial
Alex De Caluwé, Isabelle Desmoulins, Kim Cao, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 277) with videos related to
Sort By:
Page
of 28
JAMA Oncology
|
June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
JCO Precision Oncology
|
September 11, 2020
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers
Scooter Willis, Yuliang Sun, Mark Abramovitz, et al.
NPJ Breast Cancer
|
January 12, 2022
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
Sherene Loi, Roberto Salgado, Sylvia Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2019
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi, Damien Drubay, Sylvia Adams, et al.
Histopathology
|
March 3, 2024
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
Amy Ly, Victor Garcia, Kim R M Blenman, et al.
Journal of Pathology Informatics
|
December 9, 2021
A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study
Sarah N Dudgeon, Si Wen, Matthew G Hanna, et al.
JCO Precision Oncology
|
April 26, 2023
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis
Sherene Loi, Roberto Salgado, Peter Schmid, et al.
NPJ Digital Medicine
|
March 5, 2026
Clarifying validation terminologies in healthcare
Amanda Dy, Sandra M Buetow, Andrew J Bredemeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer
Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
Nature Medicine
|
June 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trial
Alex De Caluwé, Isabelle Desmoulins, Kim Cao, et al.
Page
of 28